Cancer-related breakthrough pain (Q36569562)

15 August 2017

1 reference

title

Cancer-related breakthrough pain (English)

1 reference

15 August 2017

Andrew N Davies

1

1 reference

15 August 2017

publication date

1 August 2006

1 reference

British Journal of Hospital Medicine

15 August 2017

published in

1 reference

15 August 2017

volume

67

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

414-416

1 reference

Temporary sedation with midazolam for control of severe incident pain

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

The "pain pen" for breakthrough cancer pain: a promising treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Oral transmucosal fentanyl and sufentanil for incident pain

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Morphine and alternative opioids in cancer pain: the EAPC recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Optimization of opioid therapy for preventing incident pain associated with bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Breakthrough pain: definition, prevalence and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

The use of relaxation for the promotion of comfort and pain relief in persons with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FHMED.2006.67.8.21960

10.12968/HMED.2006.67.8.21960

21 January 2018

Identifiers

DOI

0 references

1 reference